Dr. MiltieAtlas by Dr. Miltie™Healthcare Grant Intelligence

Atlas Grant Intelligence Center

Biomedical Research

Biomedical research funding, including disease-focused basic, translational, clinical, and emerging-technology research.

Atlas IndexGrant Category Intelligence
Latest verification: October 7, 2026
Verified records55
Active opportunities47
Top opportunity score96/100
States represented22

GeographyConnecticut · Arkansas · South Carolina · National · Illinois · Georgia · Idaho · Oklahoma · New Mexico · Michigan · Nebraska · Indiana · Colorado · Massachusetts · Washington · Montana · New Hampshire · North Carolina · Wisconsin · New Jersey · Arizona · Florida

← All Healthcare Grants Grant Category
Active — Recruitment Phase open through September 23, 2026 at 5:00 PM EDT Atlas Opportunity Score 96/100
Verified September 11, 2026

National Institutes of Health (NIH)

NIH Connecting the Community for Maternal Health Challenge 2.0 — Maternity Care Deserts

NIH's CCMH 2.0 challenge is recruiting U.S.-based non-academic 501(c)(3) organizations and state or federally recognized Tribes to build maternal-health research capacity, with special emphasis on maternity care deserts. Recruitment closes September 23, 2026 at 5:00 PM EDT; the multi-phase challenge offers a $3.1 million total prize purse plus training and mentoring.

Funding$3,100,000 total multi-phase prize purse. Up to 20 Training Phase winners may receive $10,000 each; up to 10 Proposal Phase winners may receive $150,000 each; up to 10 Research Phase winners share $1.4 million, including a $350,000 first-place prize, $250,000 second-place prize and up to eight $100,000 third-place prizes under current NIH rules.
DeadlineRecruitment Phase closes September 23, 2026 at 5:00 PM EDT on the official challenge portal. Later Training, Proposal and Research phase dates apply only to organizations that advance.
Required next actionConfirm the lead is a U.S.-based non-academic 501(c)(3) organization or state/federally recognized Tribe and is not the primary awardee on an NIH grant, cooperative agreement or contract at submission. Define a community-identified maternal-health research idea aligned with IMPROVE and maternity-care-desert/barriers-to-care goals, register in the official CCMH 2.0 portal, and complete Recruitment Phase submission by September 23, 2026 at 5:00 PM EDT. Review judging criteria before submission: organizational fit/capacity-building value 65%, motivation 25%, research idea 10%.
Active Atlas Opportunity Score 94/100
Verified September 13, 2026

Economic Development New Mexico (EDNM)

New Mexico Targeted Federal Match Grant – Rolling RD&D Funding

Economic Development New Mexico's Technology & Innovation Office is accepting rolling Targeted Federal Match applications for eligible New Mexico public entities and businesses pursuing priority federal research, development and deployment programs. The minimum State grant and minimum non State funding are each $1 million, and no fixed maximum State request is published.

FundingMinimum RD&D Fund grant $1,000,000 and minimum non-State funding $1,000,000. No fixed maximum State request is published; TIO may negotiate the committed amount.
DeadlineRolling, first-come, first-served while funding remains available; no fixed State application deadline.
Required next actionConfirm the applicant is pursuing a current TIO priority federal program, verify New Mexico registration status and the federal match or leverage basis, then submit the required application through TIO's online portal. Dr. Miltie/QC should not auto-submit without verified direct eligibility and an independently qualifying federal opportunity.
Open Atlas Opportunity Score 94/100
Verified October 4, 2026

Massachusetts MLSC Accelerating Research through Collaboration (ARC) Awards FY27

The Massachusetts Life Sciences Center (MLSC) is accepting FY27 applications for the Accelerating Research through Collaboration (ARC) Awards, a capital funding program for collaborative translational research conducted by a Massachusetts nonprofit research institution together with at least one Massachusetts life sciences company. Deadline: November 6, 2026 at 1 p.m. EST, as published by MLSC. Funding: […]

FundingApproximately $750,000 per award; reimbursement-based capital funding for 2-3 year projects.
DeadlineNovember 6, 2026 at 1 p.m. EST, as published by MLSC.
Required next actionApplication materials should be prepared around the required Massachusetts nonprofit-and-company collaboration structure, partner commitments, and eligible capital budget. The current application deadline is November 6, 2026 at 1:00 PM EST.
Active Atlas Opportunity Score 94/100
Verified September 22, 2026

Nebraska FY2028 NRI Collaboration Initiative

University of Nebraska FY2028 NRI Collaboration Initiative offers one-year seed grants of $10,000 to $100,000 for eligible multi-campus research collaborations. Applications are due January 15, 2027 at 5:00 PM Central Time.

Funding$10,000 to $100,000 for one year; approximately $3 million total FY2028 program budget
DeadlineJanuary 15, 2027 at 5:00 PM Central Time
Required next actionEligible University of Nebraska research faculty should register for the required October 16, 2026 annual meeting by October 9, 2026, then prepare the NuRamp application due January 15, 2027 at 5:00 PM Central Time. Confirm meaningful multi-campus collaboration or an applicable NSRI exception, targeted federal funding alignment, budget allowability, and applicant-controlled research facts. Dr. Miltie is not independently eligible as PI; any N9+ role must be research-team justified.
Open — applications due October 1, 2026 at 11:59 p.m. EST, using the time-zone label published by MLSC. Atlas Opportunity Score 94/100
Verified September 28, 2026

Massachusetts MLSC Business Builds: Life Sciences 2026

The Massachusetts Life Sciences Center (MLSC) is accepting applications for Business Builds: Life Sciences, formerly BioBoost, a capital grant program supporting life sciences companies that establish, expand, or improve Massachusetts operations, with priority for biomanufacturing and advanced medtech manufacturing. Funding: MLSC anticipates up to 10 direct manufacturing scale-up grants, generally $500,000 to $2,000,000. Deadline: October […]

Funding$500,000 to $2,000,000; MLSC anticipates up to 10 direct manufacturing scale-up grants.
DeadlineOctober 1, 2026 at 11:59 p.m. EST.
Required next actionConfirm applicant and project eligibility, document the Massachusetts location or expansion plan, identify eligible capital costs, confirm the required dollar-for-dollar 50/50 match, and submit by October 1, 2026 at 11:59 p.m. EST.
Active Atlas Opportunity Score 94/100
107 days leftVerified October 4, 2026

Colorado Clinical and Translational Sciences Institute (CCTSI)

Colorado CCTSI Pragmatic EHR Embedded Trials (PEET) 2027 Award Cycle

CCTSI is accepting mandatory competitive intent submissions through October 23, 2026 at 11:59 PM MT for one two year UCHealth pragmatic EHR embedded clinical trial. One award carries up to $180,000 in project direct costs plus $120,000 in centralized infrastructure support.

FundingOne two-year award. Up to $180,000 in project-team direct costs ($90,000/year), plus $120,000 in centralized PEET infrastructure support, for $300,000 total direct-cost support. Funding is contingent on CCTSI funding from NCATS/NIH.
DeadlineMandatory competitive Intent to Apply due October 23, 2026 at 11:59 PM Mountain Time (MT). Invited full proposals due January 29, 2027 at 11:59 PM MT.
Required next actionEligible CCTSI investigators should review the 2027 PEET RFA and submit the required Intent to Apply by October 23, 2026 at 11:59 PM MT.
Closed - October 6, 2026 at 5:00 PM local applicant-organization deadline passed. Atlas Opportunity Score 93/100
Verified October 7, 2026

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH/NIDDK — Advancing Digital Health Technology for Type 2 Diabetes (RFA-DK-26-315)

Open NIH/NIDDK R01 clinical-trial opportunity for digital-health approaches to type 2 diabetes management. Applications are due October 6, 2026 at 5:00 PM applicant-local time. Atlas rates N9+ fit as high where connected examination and telehealth workflows are part of a rigorous applicant-led study.

FundingApplication budgets are not limited but must reflect actual project needs. The NOFO anticipates three grants and describes institute funding availability across the award period.
DeadlineOctober 6, 2026 at 5:00 PM local time of the applicant organization.
Required next actionApplicants that submitted by the October 6, 2026 deadline should monitor Grants.gov and eRA Commons for validation, review, and agency communications. Other eligible research teams should monitor NIDDK and the NIH Guide for successor digital-health and diabetes research opportunities.
Open — FY2026-27 application materials and intake posted Atlas Opportunity Score 91/100
Verified October 7, 2026

Florida Department of Health

Florida FY2026-27 BRAC Biomedical Research Grants

Florida's FY2026-27 Biomedical Research Advisory Council FOA funds cancer, pediatric-cancer, and tobacco-related biomedical research through the Bankhead-Coley, James and Esther King, and Live Like Bella programs. The required Letter of Intent closed September 2, 2026 at noon ET; the application stage is now open only to applicants with a timely LOI, with full applications due October 21, 2026 at noon ET.

FundingMechanism-specific: up to $1.5 million for Bankhead-Coley/James and Esther King clinical-trial/socio-behavioral interventions and research infrastructure; other mechanisms have lower caps. Live Like Bella multicenter clinical trials are capped at $900,000.
DeadlineSeptember 2, 2026 at 12:00 PM ET (required LOI); October 21, 2026 at 12:00 PM ET (full application)
Required next actionOnly applicants that submitted the required Letter of Intent by September 2, 2026 at noon ET remain eligible for this cycle. Those applicants should complete the appropriate BRAC application in PeerNet, confirm the selected program and grant mechanism, finalize the required work plan, evaluation plan, budget and supporting materials, and submit by October 21, 2026 at noon ET.
Closed - application deadline passed October 2, 2026 at 5:00 PM local time of the applicant organization. Atlas Opportunity Score 91/100
Verified October 4, 2026

National Institutes of Health (NIH)

NIH/NICHD NExT AI Hubs for Specific Learning Disabilities (RFA-HD-27-006)

Open NIH/NICHD P20 opportunity supporting research on how artificial intelligence technologies affect learning, cognition, and socio-emotional development in children with or at risk for specific learning disabilities. Applications are due October 2, 2026 at 5:00 PM local time of the applicant organization.

FundingNICHD intends to commit $1.6 million in FY 2027 to fund up to 3 awards. Application budgets are limited to $390,000 in direct costs per year, with a maximum project period of 4 years.
DeadlineOctober 2, 2026 at 5:00 PM local time of the applicant organization.
Required next actionClosed for the 2026 application cycle. Preserve as historical reference and monitor NICHD for future NExT AI or related learning-disabilities research opportunities.
Active Atlas Opportunity Score 91/100
Verified September 21, 2026

New Jersey Commission on Brain Injury Research

New Jersey Commission on Brain Injury Research — FY 2027 Research Grants

The New Jersey Commission on Brain Injury Research has an estimated $6.5 million available across its FY 2027 research grant cycle. Individual Research Grants provide up to $150,000 per year in direct costs plus applicable indirect costs, Pilot Research Grants provide up to $75,000 per year plus applicable indirect costs, and fellowship mechanisms are also available. Applications are due October 5, 2026 at 5:00 p.m. through SAGE; the published guidelines do not separately state a time zone.

FundingEstimated $6.5 million across all FY 2027 NJCBIR grant categories. Individual Research Grants: up to $150,000 per year in direct costs plus 20% applicable indirect costs for up to three years. Pilot Research Grants: up to $75,000 per year in direct costs plus 20% applicable indirect costs for up to two years. Postdoctoral Fellowships: $100,800 per year for three years. Graduate Student Fellowships: $50,000 per year for three years, with up to $6,000 additional tuition funding. Eligible FY 2027 applicants may also request a $5,000 Research Support Supplement for qualifying activities described in the revised guidelines.
DeadlineOctober 5, 2026 at 5:00 p.m. through SAGE. The published FY 2027 guidelines do not separately state a time zone for the 5:00 p.m. deadline.
Required next actionQualified New Jersey research institutions should confirm institutional and investigator eligibility, select the appropriate FY 2027 grant mechanism, complete all SAGE forms and required attachments, and verify the operative deadline display in SAGE before final submission.
Open Atlas Opportunity Score 90/100
Verified October 1, 2026

Massachusetts Life Sciences Center

Massachusetts MLSC Research Infrastructure 2026

The Massachusetts Life Sciences Center (MLSC) Research Infrastructure program is accepting applications for capital investments in shared scientific infrastructure at eligible Massachusetts nonprofit research institutions. Funding: $1.5 million to $5 million over a 1-3 year project period. Awards are reimbursement-based after execution of a grant agreement. Deadline: November 6, 2026 at 1 p.m. EST, as […]

Funding$1.5 million to $5 million over 1-3 years; reimbursement basis after grant agreement execution.
DeadlineNovember 6, 2026 at 1 p.m. EST, as published by MLSC.
Required next actionEligible Massachusetts research institutions should assess unmet shared-infrastructure needs, confirm the applicable 2026 topic area and capital requirements, document broad external access and demand, assemble the required budget and supporting materials, and submit through the MLSC application portal by November 6, 2026 at 1:00 PM EST.
Active Atlas Opportunity Score 90/100
Verified September 18, 2026

UAMS BioVentures

2026 AR Health Ventures Accelerator (ARHVA) – Cohort 3

UAMS BioVentures is accepting Cohort 3 applications from UAMS employees developing therapeutic and health-related technologies. Selected projects may receive up to $50,000 in ARHVA-managed project support for an initial six-month development cycle.

FundingUp to $50,000 in ARHVA-managed project support per selected project; approximately two projects anticipated, subject to available resources.
DeadlineSeptember 30, 2026 at 5:00 PM (time zone not stated by BioVentures)
Required next actionAuthoritative BioVentures source rechecked September 18, 2026. The deadline remains September 30, 2026 at 5:00 PM, but BioVentures does not state the applicable time zone. Keep this record unpublished and fail closed for new applicant outreach until the time zone is authoritatively verified with at least 48 hours remaining.
Active Atlas Opportunity Score 90/100
Verified October 4, 2026

National Institutes of Health (NIH)

NIH SBIR Phase IIB Strategic Breakthrough Award — PA-27-101

Open NIH Phase IIB SBIR opportunity for U.S. small businesses that previously received a qualifying NIH SBIR or STTR Phase II award. The next standard due date is January 5, 2027 at 5:00 PM applicant-local time. Strong later-stage health-technology commercialization potential, but a 100% third-party funding match is mandatory.

FundingComponent-specific Phase IIB limits. Examples in the revised NOFO include up to $15 million for NCI, $4.5 million for NHLBI and NIAAA, and $3 million for several participating NIH institutes. Total support may not exceed $30 million. A 100% third-party funding match is mandatory.
DeadlineNext standard due date: January 5, 2027 at 5:00 PM local time of the applicant organization. Subsequent standard due dates continue through April 5, 2029. No late applications are accepted.
Required next actionConfirm a qualifying prior NIH SBIR or STTR Phase II award for the same project, verify that the application falls within the first six due dates after the Phase II budget period, confirm U.S. small-business and PI eligibility, and secure documented third-party matching funds of at least 100% of the NIH amount requested before advancing.
Active Atlas Opportunity Score 90/100
Verified September 29, 2026

National Science Foundation (NSF)

NSF 26-510 — SBIR/STTR Developing Deep Technologies

Active NSF SBIR/STTR opportunity for qualifying U.S. small businesses developing high-risk technologies. Next full-proposal deadline is November 4, 2026 at 5:00 PM submitting-organization local time. Strong N9+ direct-pursuit potential where a real technical R&D problem is being solved.

FundingApproximately $210 million anticipated across mechanisms. Phase I up to $305,000; Phase II up to $1.25 million; Fast-Track up to $1,555,555, subject to program rules and availability of funds.
DeadlineNovember 4, 2026 at 5:00 PM local time of the submitting organization. Additional recurring deadlines are listed in NSF 26-510.
Required next actionDefine a genuine technical R&D risk and commercialization thesis, confirm SBIR/STTR small-business and PI eligibility, submit the required NSF Project Pitch early enough to receive an invitation, and prepare the full proposal in Research.gov for the November 4, 2026 deadline at 5:00 p.m. in the submitting organization's local time.
Active Atlas Opportunity Score 90/100
Verified September 13, 2026

Economic Development New Mexico (EDNM)

New Mexico Capital Leverage Grant – Rolling Technology Commercialization Funding

Economic Development New Mexico's Technology & Innovation Office offers rolling Capital Leverage Grant funding for eligible New Mexico public entities and businesses advancing technology commercialization, pilot or demonstration activity, or new innovative productive capacity. The minimum State request is $1 million with at least $1 million in qualifying non State funding; Pathway 1 requests are up to $10 million and Pathway 2 requests exceed $10 million.

FundingMinimum State request $1,000,000 with at least $1,000,000 qualifying non-State funding. Pathway 1 requests up to $10,000,000; Pathway 2 requests above $10,000,000. No absolute Pathway 2 maximum is published.
DeadlineRolling while funds remain available; no fixed deadline.
Required next actionPotential applicants should confirm New Mexico eligibility and qualifying outside funding, submit the required LOI through the official portal, and advance to a full application only if invited. Dr. Miltie/QC should not auto-submit without verified applicant eligibility and qualifying outside funding.
Open - applications due January 29, 2027 Atlas Opportunity Score 90/100
Verified October 6, 2026

Northeast Delta Dental Foundation

New Hampshire Northeast Delta Dental Foundation Oral Health Grants 2027

Northeast Delta Dental Foundation is accepting oral-health grant applications serving New Hampshire through January 29, 2027. Eligible applicants include 501(c)(3) and 501(c)(4) nonprofits, governmental institutions, academic institutions, nonprofit dental clinics and FQHCs. Funding may support preventive oral-health programs, education, clinic equipment and supplies, workforce development and research.

FundingNo fixed minimum/maximum published; request project need with detailed budget
DeadlineJanuary 29, 2027; exact submission time/time zone not stated by official source
Required next actionPrepare an applicant-led oral-health proposal and submit by January 29, 2027. Reverify the Foundation page before filing and confirm any project-specific restrictions directly with the funder.
Active Atlas Opportunity Score 89/100
Verified September 29, 2026

National Institutes of Health (NIH)

NIH/CDC/FDA Parent SBIR — PA-27-100

Open NIH/CDC/FDA Parent SBIR opportunity for U.S. small businesses conducting health-related R&D. The next standard application date is January 5, 2027 at 5:00 PM applicant-local time. Strong potential for legitimate N9+ product R&D or validation, subject to SBIR eligibility and institute fit.

FundingAward budgets vary by participating NIH/CDC/FDA component and phase. The revised announcement lists component-specific NIH limits; for example, NIDDK normally allows up to $400,000 Phase I and $2.5 million Phase II. Applicants must follow the applicable component and SBA budget guidance.
DeadlineNext standard due date: January 5, 2027 at 5:00 PM local time of the applicant organization. Subsequent standard due date: April 5, 2027 at 5:00 PM local time. Announcement expiration: April 6, 2027.
Required next actionDefine a specific hypothesis-driven SBIR project, confirm the participating NIH, CDC, or FDA component and phase, verify U.S. small-business and PI eligibility plus required registrations, review component-specific budget and clinical-trial rules, and prepare for the January 5, 2027 standard due date at 5:00 PM local time of the applicant organization unless a component-specific instruction controls.
Open Atlas Opportunity Score 88/100
Verified September 30, 2026

Children's Nebraska Criss Heart Center

Children’s Nebraska Criss Heart Center Research Grant Opportunity — 2026

Children's Nebraska's Criss Heart Center is accepting hypothesis-driven pediatric cardiac research proposals through the Child Health Research Institute. Total funding may not exceed $40,000 for a one-year award, and the RFA lists a November 16, 2026 deadline at 12:00 a.m. (midnight), with no time zone stated.

FundingUp to $40,000 total funding for one year; one-time no-cost extension available. Investigator salary and indirect costs are not allowable; certain ancillary staff salaries are allowable.
DeadlineNovember 16, 2026 at 12:00 a.m. (midnight), per the RFA. No time zone is stated, and the midnight wording is operationally ambiguous; applicants should confirm the portal closing interpretation with CHRI and submit early.
Required next actionEligible investigative teams should confirm required memberships, review the RFA, prepare the required application components, and submit before the listed deadline. Applicants should verify project expenses against the current budget rules.
Active Atlas Opportunity Score 88/100
Verified September 11, 2026

Connecticut Community Foundation

Connecticut Community Foundation — Herbst Fund for Eye Research 2026

Connecticut Community Foundation’s Herbst Fund for Eye Research is listed as OPEN for the Fall 2026 cycle with a September 15, 2026 deadline. The fund supports eye research, community education on eye disease and treatment, and ophthalmic education for medical providers; first-time applicants must already have completed the Foundation’s required in-person program-officer meeting at least three weeks before the deadline.

FundingCurrent 2026 materials do not publish a universal award amount or maximum. Historical context only: $10,000 total was awarded through the Herbst Fund in 2025, consisting of two $5,000 grants; prior awards do not establish the 2026 award range.
DeadlineSeptember 15, 2026. The current central application schedule does not publish a clock-time cutoff.
Required next actionConfirm charitable eligibility and verify that any first-time applicant already completed the mandatory in-person meeting with the relevant program officer by the practical August 25, 2026 cutoff (three weeks before the September 15 deadline). Confirm GOapply access, define an eye-research, eye-health education, or ophthalmic provider-education project, verify allowability of any equipment or technology cost with the Foundation, and submit by September 15, 2026.
Active - applications due November 10, 2026 Atlas Opportunity Score 87/100
Verified October 6, 2026

NIH NIAID Clinical Research Network on Antimicrobial Resistance (AMR) – RFA-AI-27-005

NIH/NIAID is accepting applications for a seven-year Clinical Research Network on Antimicrobial Resistance. NIAID intends $18 million in FY 2027 for one award; applications are due November 10, 2026 at 5:00 PM local time of the applicant organization.

FundingNIAID intends to commit $18,000,000 in FY 2027 for one award. Application budgets are not expected to exceed $12,000,000 in direct costs per year and should reflect actual project needs. Seven-year project period.
DeadlineNovember 10, 2026 at 5:00 PM local time of the applicant organization. Earliest submission date: October 10, 2026.
Required next actionConfirm institutional readiness for the required four-center network structure and clinical-trial responsibilities, align leadership and core capabilities, review the full NOFO and current NIH policy notices, and prepare for the November 10, 2026 application deadline.